APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding

Juliane K. Czeczor, Amanda J. Genders, Kathryn Aston-Mourney, Timothy Connor, Liam G. Hall, Kyoko Hasebe, Megan Ellis, Kirstie A. De Jong, Darren C. Henstridge, Peter J. Meikle, Mark A. Febbraio, Ken Walder, Sean L. McGee

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The amyloid precursor protein (APP) generates a number of peptides when processed through different cleavage mechanisms, including the amyloid beta peptide that is implicated in the development of Alzheimer's disease. It is well established that APP via its cleaved peptides regulates aspects of neuronal metabolism. Emerging evidence suggests that amyloidogenic processing of APP can lead to altered systemic metabolism, similar to that observed in metabolic disease states. In the present study, we investigated the effect of APP deficiency on obesity-induced alterations in systemic metabolism. Compared with WT littermates, APP-deficient mice were resistant to dietinduced obesity, which was linked to higher energy expenditure and lipid oxidation throughout the dark phase and was associated with increased spontaneous physical activity. Consistent with this lean phenotype, APP-deficient mice fed a high-fat diet (HFD) had normal insulin tolerance. However, despite normal insulin action, these mice were glucose intolerant, similar to WT mice fed a HFD. This was associated with reduced plasma insulin in the early phase of the glucose tolerance test. Analysis of the pancreas showed that APP was required to maintain normal islet and β-cell mass under high fat feeding conditions. These studies show that, in addition to regulating aspects of neuronal metabolism, APP is an important regulator of whole body energy expenditure and glucose homeostasis under high fat feeding conditions.

Original languageEnglish
Pages (from-to)311-322
Number of pages12
JournalJournal of Endocrinology
Volume237
Issue number3
DOIs
Publication statusPublished - 1 Jun 2018
Externally publishedYes

Keywords

  • Amyloid precursor protein
  • Energy expenditure
  • Glucose metabolism
  • Insulin secretion
  • Obesity

Cite this

Czeczor, J. K., Genders, A. J., Aston-Mourney, K., Connor, T., Hall, L. G., Hasebe, K., ... McGee, S. L. (2018). APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding. Journal of Endocrinology, 237(3), 311-322. https://doi.org/10.1530/JOE-18-0051
Czeczor, Juliane K. ; Genders, Amanda J. ; Aston-Mourney, Kathryn ; Connor, Timothy ; Hall, Liam G. ; Hasebe, Kyoko ; Ellis, Megan ; De Jong, Kirstie A. ; Henstridge, Darren C. ; Meikle, Peter J. ; Febbraio, Mark A. ; Walder, Ken ; McGee, Sean L. / APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding. In: Journal of Endocrinology. 2018 ; Vol. 237, No. 3. pp. 311-322.
@article{f84babc6a61246f98709eac6fb81f250,
title = "APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding",
abstract = "The amyloid precursor protein (APP) generates a number of peptides when processed through different cleavage mechanisms, including the amyloid beta peptide that is implicated in the development of Alzheimer's disease. It is well established that APP via its cleaved peptides regulates aspects of neuronal metabolism. Emerging evidence suggests that amyloidogenic processing of APP can lead to altered systemic metabolism, similar to that observed in metabolic disease states. In the present study, we investigated the effect of APP deficiency on obesity-induced alterations in systemic metabolism. Compared with WT littermates, APP-deficient mice were resistant to dietinduced obesity, which was linked to higher energy expenditure and lipid oxidation throughout the dark phase and was associated with increased spontaneous physical activity. Consistent with this lean phenotype, APP-deficient mice fed a high-fat diet (HFD) had normal insulin tolerance. However, despite normal insulin action, these mice were glucose intolerant, similar to WT mice fed a HFD. This was associated with reduced plasma insulin in the early phase of the glucose tolerance test. Analysis of the pancreas showed that APP was required to maintain normal islet and β-cell mass under high fat feeding conditions. These studies show that, in addition to regulating aspects of neuronal metabolism, APP is an important regulator of whole body energy expenditure and glucose homeostasis under high fat feeding conditions.",
keywords = "Amyloid precursor protein, Energy expenditure, Glucose metabolism, Insulin secretion, Obesity",
author = "Czeczor, {Juliane K.} and Genders, {Amanda J.} and Kathryn Aston-Mourney and Timothy Connor and Hall, {Liam G.} and Kyoko Hasebe and Megan Ellis and {De Jong}, {Kirstie A.} and Henstridge, {Darren C.} and Meikle, {Peter J.} and Febbraio, {Mark A.} and Ken Walder and McGee, {Sean L.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1530/JOE-18-0051",
language = "English",
volume = "237",
pages = "311--322",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Bioscientifica",
number = "3",

}

Czeczor, JK, Genders, AJ, Aston-Mourney, K, Connor, T, Hall, LG, Hasebe, K, Ellis, M, De Jong, KA, Henstridge, DC, Meikle, PJ, Febbraio, MA, Walder, K & McGee, SL 2018, 'APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding', Journal of Endocrinology, vol. 237, no. 3, pp. 311-322. https://doi.org/10.1530/JOE-18-0051

APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding. / Czeczor, Juliane K.; Genders, Amanda J.; Aston-Mourney, Kathryn; Connor, Timothy; Hall, Liam G.; Hasebe, Kyoko; Ellis, Megan; De Jong, Kirstie A.; Henstridge, Darren C.; Meikle, Peter J.; Febbraio, Mark A.; Walder, Ken; McGee, Sean L.

In: Journal of Endocrinology, Vol. 237, No. 3, 01.06.2018, p. 311-322.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding

AU - Czeczor, Juliane K.

AU - Genders, Amanda J.

AU - Aston-Mourney, Kathryn

AU - Connor, Timothy

AU - Hall, Liam G.

AU - Hasebe, Kyoko

AU - Ellis, Megan

AU - De Jong, Kirstie A.

AU - Henstridge, Darren C.

AU - Meikle, Peter J.

AU - Febbraio, Mark A.

AU - Walder, Ken

AU - McGee, Sean L.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The amyloid precursor protein (APP) generates a number of peptides when processed through different cleavage mechanisms, including the amyloid beta peptide that is implicated in the development of Alzheimer's disease. It is well established that APP via its cleaved peptides regulates aspects of neuronal metabolism. Emerging evidence suggests that amyloidogenic processing of APP can lead to altered systemic metabolism, similar to that observed in metabolic disease states. In the present study, we investigated the effect of APP deficiency on obesity-induced alterations in systemic metabolism. Compared with WT littermates, APP-deficient mice were resistant to dietinduced obesity, which was linked to higher energy expenditure and lipid oxidation throughout the dark phase and was associated with increased spontaneous physical activity. Consistent with this lean phenotype, APP-deficient mice fed a high-fat diet (HFD) had normal insulin tolerance. However, despite normal insulin action, these mice were glucose intolerant, similar to WT mice fed a HFD. This was associated with reduced plasma insulin in the early phase of the glucose tolerance test. Analysis of the pancreas showed that APP was required to maintain normal islet and β-cell mass under high fat feeding conditions. These studies show that, in addition to regulating aspects of neuronal metabolism, APP is an important regulator of whole body energy expenditure and glucose homeostasis under high fat feeding conditions.

AB - The amyloid precursor protein (APP) generates a number of peptides when processed through different cleavage mechanisms, including the amyloid beta peptide that is implicated in the development of Alzheimer's disease. It is well established that APP via its cleaved peptides regulates aspects of neuronal metabolism. Emerging evidence suggests that amyloidogenic processing of APP can lead to altered systemic metabolism, similar to that observed in metabolic disease states. In the present study, we investigated the effect of APP deficiency on obesity-induced alterations in systemic metabolism. Compared with WT littermates, APP-deficient mice were resistant to dietinduced obesity, which was linked to higher energy expenditure and lipid oxidation throughout the dark phase and was associated with increased spontaneous physical activity. Consistent with this lean phenotype, APP-deficient mice fed a high-fat diet (HFD) had normal insulin tolerance. However, despite normal insulin action, these mice were glucose intolerant, similar to WT mice fed a HFD. This was associated with reduced plasma insulin in the early phase of the glucose tolerance test. Analysis of the pancreas showed that APP was required to maintain normal islet and β-cell mass under high fat feeding conditions. These studies show that, in addition to regulating aspects of neuronal metabolism, APP is an important regulator of whole body energy expenditure and glucose homeostasis under high fat feeding conditions.

KW - Amyloid precursor protein

KW - Energy expenditure

KW - Glucose metabolism

KW - Insulin secretion

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85047476529&partnerID=8YFLogxK

U2 - 10.1530/JOE-18-0051

DO - 10.1530/JOE-18-0051

M3 - Article

VL - 237

SP - 311

EP - 322

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 3

ER -

Czeczor JK, Genders AJ, Aston-Mourney K, Connor T, Hall LG, Hasebe K et al. APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding. Journal of Endocrinology. 2018 Jun 1;237(3):311-322. https://doi.org/10.1530/JOE-18-0051